These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 373335)

  • 1. [Immunological reactions in the secretions of volunteers vaccinated against influenza by aerosol and intranasally].
    Pershin BB; Romanov VL; Kvirikadze VV; Stefani DV; Torichneva LIu
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Mar; (3):35-9. PubMed ID: 373335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secretory and serum response after intranasal influenza vaccination with A/Victoria attenuated live virus].
    Crifò S; Filiaci F; Pelosio A; Rocchi G
    Boll Soc Ital Biol Sper; 1978 Jun; 54(11):1021-6. PubMed ID: 743410
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody in tears, saliva and nasal secretions following oral immunization of humans with inactivated influenza virus vaccine.
    Bergmann KC; Waldman RH; Tischner H; Pohl WD
    Int Arch Allergy Appl Immunol; 1986; 80(1):107-9. PubMed ID: 3957442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology.
    Petrescu A; Mihail A; Samuel I; Teodosiu O; Isaia G; Ganea E; Motaş C
    Virologie; 1979; 30(2):109-15. PubMed ID: 111408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate.
    Ainai A; Suzuki T; Tamura SI; Hasegawa H
    Viral Immunol; 2017; 30(6):451-462. PubMed ID: 28650274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines.
    Shvartsman YS; Agranovskaya EN; Zykov MP
    J Infect Dis; 1977 May; 135(5):697-705. PubMed ID: 858947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes.
    Moldoveanu Z; Clements ML; Prince SJ; Murphy BR; Mestecky J
    Vaccine; 1995 Aug; 13(11):1006-12. PubMed ID: 8525683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity.
    Bakke H; Samdal HH; Holst J; Oftung F; Haugen IL; Kristoffersen AC; Haugan A; Janakova L; Korsvold GE; Krogh G; Andersen EA; Djupesland P; Holand T; Rappuoli R; Haneberg B
    Scand J Immunol; 2006 Mar; 63(3):223-31. PubMed ID: 16499576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization.
    Avtushenko SS; Sorokin EM; Zoschenkova NY; Zacharova NG; Naichin AN
    J Biotechnol; 1996 Jan; 44(1-3):21-8. PubMed ID: 8717382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness.
    Langley JM; Aoki F; Ward BJ; McGeer A; Angel JB; Stiver G; Gorfinkel I; Shu D; White L; Lasko B; Dzongowski P; Papp K; Alexander M; Boivin G; Fries L
    Vaccine; 2011 Feb; 29(10):1921-8. PubMed ID: 21219987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of saliva for study in the immunoenzyme analysis of postvaccinal and postinfectious immunity to influenza].
    Naĭkhin AN; Mikhaĭlov AA; Kustikova IuG; Tsybalova LM; Klimovich VB; Artem'eva SA; Krasheniuk AI; Katorgina LG; Kim TN; Denisov GM
    Vopr Virusol; 1993; 38(5):201-4. PubMed ID: 8284915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
    Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
    J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration.
    Terauchi Y; Sano K; Ainai A; Saito S; Taga Y; Ogawa-Goto K; Tamura SI; Odagiri T; Tashiro M; Fujieda M; Suzuki T; Hasegawa H
    Hum Vaccin Immunother; 2018 Jun; 14(6):1351-1361. PubMed ID: 29425074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.
    Hirabayashi Y; Kurata H; Funato H; Nagamine T; Aizawa C; Tamura S; Shimada K; Kurata T
    Vaccine; 1990 Jun; 8(3):243-8. PubMed ID: 2363302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization against influenza in humans using an oral enteric-coated killed virus vaccine.
    Lazzell V; Waldman RH; Rose C; Khakoo R; Jacknowitz A; Howard S
    J Biol Stand; 1984 Jul; 12(3):315-21. PubMed ID: 6480615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 18. [Determination of pneumococcus antibodies in secretions in acute pneumonia in children].
    Ulanova MA; Padiukov LN; Katosova LK; Tolkachev AM
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Sep; (9):112-5. PubMed ID: 3318235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interrelationships between serum and secretory antibodies in immunization with live influenza vaccine].
    Shvartsman IaS; Krylov VA; Agranovskaia EN; Mal'tseva AI
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):35-8. PubMed ID: 128269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans.
    Overton ET; Goepfert PA; Cunningham P; Carter WA; Horvath J; Young D; Strayer DR
    Vaccine; 2014 Sep; 32(42):5490-5. PubMed ID: 25128802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.